Andrew Atz to Double-Blind Method
This is a "connection" page, showing publications Andrew Atz has written about Double-Blind Method.
Connection Strength
0.446
-
Corticosteroid Therapy in Neonates Undergoing Cardiopulmonary Bypass: Randomized?Controlled Trial. J Am Coll Cardiol. 2019 08 06; 74(5):659-668.
Score: 0.122
-
Effect of Sildenafil on Pressure-Volume Loop Measures of Ventricular Function in Fontan Patients. Pediatr Cardiol. 2016 Jan; 37(1):184-91.
Score: 0.094
-
Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age. N Engl J Med. 2022 05 26; 386(21):2011-2023.
Score: 0.037
-
Carvedilol Does Not Improve Exercise Performance in Fontan Patients: Results of a Crossover Trial. Pediatr Cardiol. 2021 Apr; 42(4):934-941.
Score: 0.034
-
Comparison of echocardiographic measurements to invasive measurements of diastolic function in infants with single ventricle physiology: a report from the Pediatric Heart Network Infant Single Ventricle Trial. Cardiol Young. 2019 Oct; 29(10):1248-1256.
Score: 0.031
-
Preoperative steroid treatment does not improve markers of inflammation after cardiac surgery in neonates: results from a randomized trial. J Thorac Cardiovasc Surg. 2014 Mar; 147(3):902-8.
Score: 0.020
-
Standardized preoperative corticosteroid treatment in neonates undergoing cardiac surgery: results from a randomized trial. J Thorac Cardiovasc Surg. 2011 Dec; 142(6):1523-9.
Score: 0.017
-
Evaluation of Kawasaki disease risk-scoring systems for intravenous immunoglobulin resistance. J Pediatr. 2011 May; 158(5):831-835.e3.
Score: 0.017
-
Enalapril in infants with single ventricle: results of a multicenter randomized trial. Circulation. 2010 Jul 27; 122(4):333-40.
Score: 0.016
-
Rationale and design of a trial of angiotensin-converting enzyme inhibition in infants with single ventricle. Am Heart J. 2009 Jan; 157(1):37-45.
Score: 0.015
-
Randomized trial of pulsed corticosteroid therapy for primary treatment of Kawasaki disease. N Engl J Med. 2007 Feb 15; 356(7):663-75.
Score: 0.013
-
A population pharmacokinetic analysis of milrinone in pediatric patients after cardiac surgery. J Pharmacokinet Pharmacodyn. 2004 Feb; 31(1):43-59.
Score: 0.010
-
Efficacy and safety of milrinone in preventing low cardiac output syndrome in infants and children after corrective surgery for congenital heart disease. Circulation. 2003 Feb 25; 107(7):996-1002.
Score: 0.010
-
Prophylactic intravenous use of milrinone after cardiac operation in pediatrics (PRIMACORP) study. Prophylactic Intravenous Use of Milrinone After Cardiac Operation in Pediatrics. Am Heart J. 2002 Jan; 143(1):15-21.
Score: 0.009